Abstract
Little is known about the intracellular actions of imipramine (IMI) in the regulation of ion channels. We tested the action of IMI on the intracellular cascade that regulates M current (I M) in superior cervical ganglion neurones (SCGs). Dialysis of the cells with GDPβS, a G protein signaling blocker, did not disrupt the inhibition of I M. When we incubated the cells with the phospholipase C (PLC) inhibitor U73122, it prevented the I M inhibition by IMI. Also, when we dialyzed the cells with an intracellular Ca 2+ chelator, it did not disrupt I M inhibition by IMI, as occurs in the M 1 cascade. When we incubated the cells with the generic kinase inhibitor wortmannin, it prevented the recovery of I M from the inhibition by IMI. Also, when we applied phosphatidylinositol 4,5-bisphosphate (PIP 2) intracellularly, it diminished the inhibition of I M by IMI. Our findings suggest that PLC is the target for IMI, that recovery of I M needs lipid phosphorylation for PIP 2 resynthesis, and that IMI inhibits I M by activating a PLC-dependent pathway, likely by decreasing the concentration of PIP 2. © 2005 Nature Publishing Group. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Quintero, J. L., Arenas, M. I., & García, D. E. (2005). The antidepressant imipramine inhibits M current by activating a phosphatidylinositol 4,5-bisphosphate (PIP 2)-dependent pathway in rat sympathetic neurones. British Journal of Pharmacology, 145(6), 837–843. https://doi.org/10.1038/sj.bjp.0706239
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.